Sora Ely, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Washington, DCNPI 1346627007
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,303 of the $5,303 with a category attached, or 81.1%. 13 manufacturers reported payments, led by Johnson & Johnson at 26.7% of the total.
Across 42 payments — averaging $126.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AstraZeneca$1K
- Intuitive Surgical$1K
- Davol Inc.$436
- GSK$273
- Integra Lifesciences Corporation$174
- plus $691 from 7 others
What the payments were for
- Food & beverage$4,30381%
- Education$1,00019%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $1,417 |
| AstraZeneca | 13 | $1,190 |
| Intuitive Surgical | 3 | $1,121 |
| Davol Inc. | 2 | $436 |
| GSK | 2 | $273 |
| Integra Lifesciences Corporation | 1 | $174 |
| Astrazeneca UK Limited | 2 | $143 |
| Grifols USA, LLC | 1 | $133 |
| Sanofi | 1 | $118 |
| Amgen | 1 | $118 |
| Tempus AI, Inc | 1 | $110 |
| Medtronic | 2 | $51 |
| Genentech USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ECHELON ENDOPATH$1,354
- DAVINCI XI$1,000
- INTEGRA$521
- ARISTA AH FLEXITIP$436
- TEZSPIRE$357
- FASENRA$239
- NUCALA$178
- INTEGRA DERMAL REGENERATION TEMPLATE$174
- PRIMATRIX$174
- Prolastin-C Liquid$133
- BREZTRI$131
- DUPIXENT$118
- XT CDX$110
- SURGIFLO Hemostatic Matrix$103
How this compares
$5,303 in reported general payments places this provider in the 60th percentile of 25 thoracic surgery (cardiothoracic vascular surgery) providers in District of Columbia.
See all thoracic surgery (cardiothoracic vascular surgery) providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Washington
- Keith MortmanWashington$170K
- John LazarWashington$79K
- Salim AzizWashington$24K
- Gal LevyWashington$23K
- Farzad NajamWashington$19K
- Steven BoyceWashington$13K
- Jeffrey CohenWashington$11K
- Gregory TrachiotisWashington$10K
- Deyanira PrasteinWashington$6K
- Dean SchraufnagelWashington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.